InvestorsObserver
×
News Home

Is Mirum Pharmaceuticals Inc (MIRM) a Good Choice in Biotechnology Thursday?

Thursday, November 30, 2023 12:34 PM | InvestorsObserver Analysts

Mentioned in this article

Is Mirum Pharmaceuticals Inc (MIRM) a Good Choice in Biotechnology Thursday?

The 85 rating InvestorsObserver gives to Mirum Pharmaceuticals Inc (MIRM) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 98 percent of stocks in the Biotechnology industry, MIRM’s 85 overall rating means the stock scores better than 85 percent of all stocks.

Overall Score - 85
MIRM has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on MIRM!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 85 would rank higher than 85 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Mirum Pharmaceuticals Inc Stock Today?

Mirum Pharmaceuticals Inc (MIRM) stock is higher by 3.33% while the S&P 500 has fallen -0.22% as of 12:29 PM on Thursday, Nov 30. MIRM is up $1.06 from the previous closing price of $31.65 on volume of 196,256 shares. Over the past year the S&P 500 is up 11.28% while MIRM is up 75.39%. MIRM lost -$4.30 per share the over the last 12 months. Click Here to get the full Stock Report for Mirum Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App